Interaction between monobactams and Streptomyces R61 DD-carboxypeptidase

Area of Science:

• Microbiology
• Biochemistry
• Medicinal Chemistry

Background:

• Beta-lactam antibiotics are crucial in treating bacterial infections.
• Monobactams represent a novel class of monocyclic beta-lactam antibiotics.
• Understanding their mechanism of action is vital for antibiotic development.

Purpose of the Study:

• To investigate the binding mechanism of monobactams to Streptomyces R61 DD-carboxypeptidase.
• To compare the interaction of monobactams with DD-carboxypeptidase to that of bicyclic beta-lactams.

Main Methods:

• Enzyme inhibition assays using diisopropylfluorophosphate and alpha-dicarbonyls.
• Determination of binding stoichiometry.
• Analysis of radiolabeled enzyme and bound beta-lactams using partial proteolysis.
• Kinetic studies on the release rates of bound beta-lactams.
• Characterization of hydrolysis and hydroxylaminolysis products.

Main Results:

• Monobactams covalently bind to Streptomyces R61 DD-carboxypeptidase.
• The binding pattern closely resembles that of bicyclic beta-lactams, particularly cephalosporins.
• Evidence includes enzyme inhibition, binding stoichiometry, proteolysis patterns, release rates, and product analysis.

Conclusions:

• Monobactams interact with DD-carboxypeptidase through a mechanism analogous to cephalosporins.
• This suggests a conserved binding mode for beta-lactam antibiotics.
• The findings contribute to understanding beta-lactam antibiotic mechanisms and potential for novel drug design.